SEC Form 4 · accession 0001571049-17-005185
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack Bendheim
Officer — President and CEO · Director · 10% Owner
Period of report
May 17, 2017
Accepted (ET)
May 19, 2017 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2,F3,F1 | May 17, 2017 | S | 16,000 | $34.20 | D | 55,025 | I | See |
| Class A Common StockF2,F4,F1 | May 18, 2017 | S | 16,000 | $34.09 | D | 39,025 | I | See |
| Class A Common StockF2,F5,F1 | May 19, 2017 | S | 16,000 | $34.16 | D | 23,025 | I | See |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI Co., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC on March 14, 2016.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.50, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.35, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.50, inclusive